Vault-13

Bellevue Group AG

ZURICH, V8 · CIK 1674546 · 13F filing filed 2021-08-12

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

Other 13F filers in this group: Bellevue Asset Management AG files a notice

$10.2bn reported value +8.4% vs Q1 2021
213positions
30.3%in top 10
12 new 77 added 41 reduced 15 sold out vs Q1 2021

Options: 1 call positions ($39.0k notional), 0 put positions (— notional) – listed below, not included above.

This report includes the holdings of 3 other managers that share the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 MODERNA INC COM MRNA MRNA 2,542,300 $597.4m5.83% 5.83% ReducedShares held: Q3 2020 3.3m, Q4 2020 2.9m, Q1 2021 2.8m, Q2 2021 2.5m -267.6k -267,650 -9.5%
2 IONIS PHARMACEUTICALS INC COM IONS IONS 9,930,245 $396.1m3.87% 3.87% AddedShares held: Q3 2020 8.7m, Q4 2020 9.1m, Q1 2021 9.0m, Q2 2021 9.9m +946.0k +946,011 10.5%
3 VERTEX PHARMACEUTICALS INC COM VRTX VRTX 1,733,694 $349.6m3.41% 3.41% AddedShares held: Q3 2020 960.6k, Q4 2020 1.2m, Q1 2021 1.4m, Q2 2021 1.7m +357.0k +356,990 25.9%
4 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 3,017,751 $293.7m2.87% 2.87% ReducedShares held: Q3 2020 3.3m, Q4 2020 3.4m, Q1 2021 3.3m, Q2 2021 3.0m -256.8k -256,800 -7.8%
5 ARGENX SE SPONSORED ADR ARGX ARGX 974,038 $293.3m2.86% 2.86% AddedShares held: Q3 2020 959.0k, Q4 2020 945.3k, Q1 2021 954.6k, Q2 2021 974.0k +19.5k +19,484 2.0%
6 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 1,549,092 $262.6m2.56% 2.56% ReducedShares held: Q3 2020 1.6m, Q4 2020 1.6m, Q1 2021 1.6m, Q2 2021 1.5m -78.0k -78,022 -4.8%
7 INCYTE CORP COM INCY INCY 2,971,400 $250.0m2.44% 2.44% ReducedShares held: Q3 2020 3.3m, Q4 2020 3.0m, Q1 2021 3.0m, Q2 2021 3.0m -34.3k -34,300 -1.1%
8 AGIOS PHARMACEUTICALS INC COM AGIO AGIO 4,352,992 $239.9m2.34% 2.34% ReducedShares held: Q3 2020 4.2m, Q4 2020 4.2m, Q1 2021 4.5m, Q2 2021 4.4m -184.1k -184,100 -4.1%
9 FATE THERAPEUTICS INC COM FATE FATE 2,613,536 $226.8m2.21% 2.21% AddedShares held: Q3 2020 2.2m, Q4 2020 2.1m, Q1 2021 2.2m, Q2 2021 2.6m +404.2k +404,200 18.3%
10 MACROGENICS INC COM MGNX MGNX 7,376,026 $198.1m1.93% 1.93% AddedShares held: Q3 2020 5.3m, Q4 2020 5.9m, Q1 2021 6.0m, Q2 2021 7.4m +1.3m +1,348,100 22.4%
11 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 202,095 $185.9m1.81% 1.81% ReducedShares held: Q3 2020 153.2k, Q4 2020 196.0k, Q1 2021 220.8k, Q2 2021 202.1k -18.7k -18,680 -8.5%
12 BIOGEN INC COM BIIB BIIB 528,100 $182.9m1.79% 1.79% ReducedShares held: Q3 2020 8.6k, Q4 2020 564.0k, Q1 2021 558.4k, Q2 2021 528.1k -30.3k -30,300 -5.4%
13 ELEVANCE HEALTH INC COM ELV ELV 465,976 $177.9m1.74% 1.74% AddedShares held: Q3 2020 349.1k, Q4 2020 335.8k, Q1 2021 385.5k, Q2 2021 466.0k +80.4k +80,428 20.9%
14 ARVINAS INC COM ARVN ARVN 2,237,403 $172.3m1.68% 1.68% AddedShares held: Q3 2020 1.6m, Q4 2020 2.2m, Q1 2021 2.1m, Q2 2021 2.2m +165.9k +165,900 8.0%
15 ABBOTT LABS COM ABT ABT 1,377,499 $159.7m1.56% 1.56% ReducedShares held: Q3 2020 1.3m, Q4 2020 1.4m, Q1 2021 1.4m, Q2 2021 1.4m -15.5k -15,500 -1.1%
16 CRISPR THERAPEUTICS AG NAMEN AKT CRSP CRSP 966,884 $156.5m1.53% 1.53% ReducedShares held: Q3 2020 949.3k, Q4 2020 909.7k, Q1 2021 978.4k, Q2 2021 966.9k -11.5k -11,500 -1.2%
17 INTRA-CELLULAR THERAPIES INC COM ITCI ITCI 3,609,919 $147.4m1.44% 1.44% ReducedShares held: Q3 2020 3.6m, Q4 2020 3.7m, Q1 2021 3.7m, Q2 2021 3.6m -50.0k -50,000 -1.4%
18 RADIUS HEALTH INC COM NEW RDUS RDUS 7,531,414 $137.4m1.34% 1.34% UnchangedShares held: Q3 2020 7.4m, Q4 2020 7.5m, Q1 2021 7.5m, Q2 2021 7.5m
19 UNITEDHEALTH GROUP INC COM UNH UNH 343,051 $137.4m1.34% 1.34% ReducedShares held: Q3 2020 324.1k, Q4 2020 306.0k, Q1 2021 357.4k, Q2 2021 343.1k -14.3k -14,330 -4.0%
20 SAGE THERAPEUTICS INC COM SAGE SAGE 2,364,204 $134.3m1.31% 1.31% AddedShares held: Q3 2020 1.6m, Q4 2020 1.6m, Q1 2021 1.8m, Q2 2021 2.4m +553.5k +553,500 30.6%
21 DANAHER CORPORATION COM DHR DHR 482,940 $129.6m1.27% 1.27% AddedShares held: Q3 2020 453.4k, Q4 2020 533.8k, Q1 2021 473.1k, Q2 2021 482.9k +9.8k +9,800 2.1%
22 HUMANA INC COM HUM HUM 282,755 $125.2m1.22% 1.22% ReducedShares held: Q3 2020 244.0k, Q4 2020 237.1k, Q1 2021 288.7k, Q2 2021 282.8k -6.0k -5,964 -2.1%
23 MYOVANT SCIENCES LTD COM MYOV MYOV 5,269,039 $120.0m1.17% 1.17% AddedShares held: Q3 2020 5.1m, Q4 2020 4.8m, Q1 2021 5.2m, Q2 2021 5.3m +75.0k +75,000 1.4%
24 BECTON DICKINSON & CO COM BDX BDX 460,965 $112.1m1.09% 1.09% UnchangedShares held: Q3 2020 260.8k, Q4 2020 327.8k, Q1 2021 461.0k, Q2 2021 461.0k
25 AXONICS INC COM AXNX AXNX 1,730,471 $109.7m1.07% 1.07% AddedShares held: Q3 2020 644.9k, Q4 2020 1.2m, Q1 2021 1.5m, Q2 2021 1.7m +274.2k +274,197 18.8%
26 DEXCOM INC COM DXCM DXCM 244,776 $104.5m1.02% 1.02% AddedShares held: Q3 2020 121.7k, Q4 2020 213.3k, Q1 2021 216.2k, Q2 2021 244.8k +28.6k +28,583 13.2%
27 CENTENE CORP DEL COM CNC CNC 1,386,297 $101.1m0.99% 0.99% AddedShares held: Q3 2020 1.0m, Q4 2020 1.2m, Q1 2021 1.3m, Q2 2021 1.4m +95.7k +95,700 7.4%
28 HALOZYME THERAPEUTICS INC COM HALO HALO 2,224,466 $101.0m0.99% 0.99% ReducedShares held: Q3 2020 5.5m, Q4 2020 4.0m, Q1 2021 3.0m, Q2 2021 2.2m -787.5k -787,500 -26.1%
29 BOSTON SCIENTIFIC CORP COM BSX BSX 2,326,787 $99.5m0.97% 0.97% UnchangedShares held: Q3 2020 1.9m, Q4 2020 2.2m, Q1 2021 2.3m, Q2 2021 2.3m
30 TANDEM DIABETES CARE INC COM NEW TNDM TNDM 1,020,368 $99.4m0.97% 0.97% AddedShares held: Q3 2020 313.4k, Q4 2020 385.2k, Q1 2021 527.1k, Q2 2021 1.0m +493.2k +493,234 93.6%
31 SHOCKWAVE MED INC COM SWAV SWAV 516,915 $98.1m0.96% 0.96% AddedShares held: Q3 2020 461.3k, Q4 2020 425.3k, Q1 2021 484.6k, Q2 2021 516.9k +32.4k +32,351 6.7%
32 BRISTOL-MYERS SQUIBB CO COM BMY BMY 1,463,432 $97.8m0.95% 0.95% ReducedShares held: Q3 2020 1.6m, Q4 2020 1.8m, Q1 2021 2.1m, Q2 2021 1.5m -621.7k -621,720 -29.8%
33 JAZZ PHARMACEUTICALS PLC SHS USD JAZZ JAZZ 544,750 $96.8m0.94% 0.94% ReducedShares held: Q3 2020 356.4k, Q4 2020 388.9k, Q1 2021 550.6k, Q2 2021 544.8k -5.9k -5,900 -1.1%
34 RELAY THERAPEUTICS INC COM RLAY RLAY 2,640,962 $96.6m0.94% 0.94% AddedShares held: Q3 2020 1.3m, Q4 2020 1.4m, Q1 2021 1.9m, Q2 2021 2.6m +709.6k +709,618 36.7%
35 ALIGN TECHNOLOGY INC COM ALGN ALGN 156,770 $95.8m0.94% 0.94% AddedShares held: Q3 2020 84.6k, Q4 2020 112.8k, Q1 2021 144.0k, Q2 2021 156.8k +12.8k +12,810 8.9%
36 ESPERION THERAPEUTICS INC NE COM ESPR ESPR 4,519,164 $95.6m0.93% 0.93% AddedShares held: Q3 2020 5.5m, Q4 2020 5.1m, Q1 2021 4.0m, Q2 2021 4.5m +530.0k +530,000 13.3%
37 ACCOLADE INC COM ACCD ACCD 1,724,699 $93.7m0.91% 0.91% AddedShares held: Q3 2020 209.3k, Q4 2020 385.3k, Q1 2021 1.6m, Q2 2021 1.7m +163.6k +163,578 10.5%
38 EDWARDS LIFESCIENCES CORP COM EW EW 890,256 $92.2m0.90% 0.90% UnchangedShares held: Q3 2020 827.8k, Q4 2020 826.9k, Q1 2021 890.3k, Q2 2021 890.3k
39 STRYKER CORPORATION COM SYK SYK 344,514 $89.5m0.87% 0.87% UnchangedShares held: Q3 2020 322.8k, Q4 2020 338.0k, Q1 2021 344.5k, Q2 2021 344.5k
40 INSMED INC COM PAR $.01 INSM INSM 3,120,901 $88.8m0.87% 0.87% AddedShares held: Q3 2020 1.2m, Q4 2020 1.6m, Q1 2021 2.5m, Q2 2021 3.1m +643.7k +643,735 26.0%
41 INSULET CORP COM PODD PODD 322,119 $88.4m0.86% 0.86% ReducedShares held: Q3 2020 269.9k, Q4 2020 337.5k, Q1 2021 434.2k, Q2 2021 322.1k -112.1k -112,069 -25.8%
42 BEAM THERAPEUTICS INC COM BEAM BEAM 612,821 $78.9m0.77% 0.77% AddedShares held: Q3 2020 0, Q4 2020 396.8k, Q1 2021 566.8k, Q2 2021 612.8k +46.0k +46,000 8.1%
43 EVOLENT HEALTH INC CL A EVH EVH 3,638,411 $76.8m0.75% 0.75% AddedShares held: Q3 2020 3.3m, Q4 2020 3.1m, Q1 2021 3.5m, Q2 2021 3.6m +109.9k +109,864 3.1%
44 HILL ROM HLDGS INC COM HRC HRC 673,878 $76.5m0.75% 0.75% AddedShares held: Q3 2020 571.1k, Q4 2020 652.5k, Q1 2021 660.6k, Q2 2021 673.9k +13.2k +13,250 2.0%
45 MOLECULAR TEMPLATES INC COM COM 9,628,621 $75.3m0.74% 0.74% AddedShares held: Q3 2020 5.0m, Q4 2020 6.4m, Q1 2021 8.1m, Q2 2021 9.6m +1.5m +1,480,516 18.2%
46 IDEXX LABS INC COM IDXX IDXX 118,120 $74.6m0.73% 0.73% AddedShares held: Q3 2020 78.4k, Q4 2020 78.1k, Q1 2021 91.2k, Q2 2021 118.1k +26.9k +26,871 29.4%
47 BAXTER INTL INC COM BAX BAX 900,623 $72.5m0.71% 0.71% AddedShares held: Q3 2020 474.6k, Q4 2020 474.6k, Q1 2021 474.6k, Q2 2021 900.6k +426.0k +426,000 89.8%
48 INSPIRE MED SYS INC COM INSP INSP 373,226 $72.1m0.70% 0.70% AddedShares held: Q3 2020 273.0k, Q4 2020 299.2k, Q1 2021 320.2k, Q2 2021 373.2k +53.0k +53,038 16.6%
49 NEKTAR THERAPEUTICS COM COM 4,101,404 $70.4m0.69% 0.69% AddedShares held: Q3 2020 3.6m, Q4 2020 3.9m, Q1 2021 4.0m, Q2 2021 4.1m +146.8k +146,800 3.7%
50 ESSA PHARMA INC COM NEW EPI EPI 2,459,814 $70.3m0.69% 0.69% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 1.8m, Q2 2021 2.5m +634.0k +634,000 34.7%
51 HCA HEALTHCARE INC COM HCA HCA 334,273 $69.1m0.67% 0.67% ReducedShares held: Q3 2020 345.1k, Q4 2020 367.0k, Q1 2021 374.6k, Q2 2021 334.3k -40.3k -40,290 -10.8%
52 GENERATION BIO CO COM COM 2,478,180 $66.7m0.65% 0.65% AddedShares held: Q3 2020 1.9m, Q4 2020 2.3m, Q1 2021 2.4m, Q2 2021 2.5m +85.0k +85,000 3.5%
53 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 2,297,625 $66.4m0.65% 0.65% AddedShares held: Q3 2020 2.8m, Q4 2020 2.3m, Q1 2021 2.1m, Q2 2021 2.3m +166.5k +166,500 7.8%
54 CHARLES RIV LABS INTL INC COM CRL CRL 178,270 $65.9m0.64% 0.64% ReducedShares held: Q3 2020 351.1k, Q4 2020 143.0k, Q1 2021 188.4k, Q2 2021 178.3k -10.1k -10,115 -5.4%
55 SILK RD MED INC COM SILK SILK 1,293,759 $61.9m0.60% 0.60% AddedShares held: Q3 2020 300.6k, Q4 2020 372.9k, Q1 2021 1.2m, Q2 2021 1.3m +134.8k +134,835 11.6%
56 HOLOGIC INC COM HOLX HOLX 913,752 $61.0m0.60% 0.60% UnchangedShares held: Q3 2020 697.0k, Q4 2020 908.6k, Q1 2021 913.8k, Q2 2021 913.8k
57 THE CIGNA GROUP COM CI CI 256,742 $60.9m0.59% 0.59% ReducedShares held: Q3 2020 335.7k, Q4 2020 413.2k, Q1 2021 448.2k, Q2 2021 256.7k -191.4k -191,420 -42.7%
58 OMNICELL COM COM OMCL OMCL 393,583 $59.6m0.58% 0.58% AddedShares held: Q3 2020 278.4k, Q4 2020 296.3k, Q1 2021 327.9k, Q2 2021 393.6k +65.7k +65,664 20.0%
59 REGENERON PHARMACEUTICALS COM REGN REGN 105,660 $59.0m0.58% 0.58% AddedShares held: Q3 2020 20.0k, Q4 2020 27.7k, Q1 2021 35.8k, Q2 2021 105.7k +69.9k +69,860 195.1%
60 REVOLUTION MEDICINES INC COM RVMD RVMD 1,854,805 $58.9m0.57% 0.57% AddedShares held: Q3 2020 0, Q4 2020 40.0k, Q1 2021 1.1m, Q2 2021 1.9m +789.0k +789,035 74.0%
61 PACIFIC BIOSCIENCES CALIF IN COM PACB PACB 1,643,159 $57.5m0.56% 0.56% AddedShares held: Q3 2020 3.9m, Q4 2020 1.7m, Q1 2021 1.6m, Q2 2021 1.6m +25.7k +25,654 1.6%
62 GLOBUS MED INC CL A GMED GMED 729,420 $56.6m0.55% 0.55% AddedShares held: Q3 2020 409.7k, Q4 2020 584.6k, Q1 2021 647.5k, Q2 2021 729.4k +81.9k +81,911 12.7%
63 BIO RAD LABS INC CL A BIO BIO 87,301 $56.2m0.55% 0.55% ReducedShares held: Q3 2020 78.2k, Q4 2020 64.4k, Q1 2021 100.2k, Q2 2021 87.3k -12.9k -12,901 -12.9%
64 VEEVA SYS INC CL A COM VEEV VEEV 172,647 $53.7m0.52% 0.52% AddedShares held: Q3 2020 95.4k, Q4 2020 111.9k, Q1 2021 152.8k, Q2 2021 172.6k +19.8k +19,847 13.0%
65 EXELIXIS INC COM EXEL EXEL 2,932,000 $53.4m0.52% 0.52% ReducedShares held: Q3 2020 3.1m, Q4 2020 2.9m, Q1 2021 2.9m, Q2 2021 2.9m -12.5k -12,500 -0.4%
66 MOLINA HEALTHCARE INC COM MOH MOH 198,734 $50.3m0.49% 0.49% ReducedShares held: Q3 2020 164.6k, Q4 2020 199.7k, Q1 2021 205.2k, Q2 2021 198.7k -6.5k -6,500 -3.2%
67 PENUMBRA INC COM PEN PEN 182,125 $49.9m0.49% 0.49% AddedShares held: Q3 2020 121.2k, Q4 2020 147.5k, Q1 2021 179.9k, Q2 2021 182.1k +2.2k +2,250 1.2%
68 ABIOMED INC COM ABMD ABMD 151,178 $47.2m0.46% 0.46% AddedShares held: Q3 2020 101.4k, Q4 2020 107.6k, Q1 2021 142.7k, Q2 2021 151.2k +8.5k +8,494 6.0%
69 GUARDANT HEALTH INC COM GH GH 379,609 $47.1m0.46% 0.46% AddedShares held: Q3 2020 162.4k, Q4 2020 179.2k, Q1 2021 302.9k, Q2 2021 379.6k +76.7k +76,743 25.3%
70 10X GENOMICS INC CL A COM TXG TXG 232,672 $45.6m0.44% 0.44% AddedShares held: Q3 2020 154.0k, Q4 2020 165.1k, Q1 2021 229.0k, Q2 2021 232.7k +3.6k +3,633 1.6%
71 ZIMMER BIOMET HOLDINGS INC COM ZBH ZBH 280,082 $45.0m0.44% 0.44% UnchangedShares held: Q3 2020 225.7k, Q4 2020 244.8k, Q1 2021 280.1k, Q2 2021 280.1k
72 MEDTRONIC PLC SHS MDT MDT 359,625 $44.6m0.44% 0.44% AddedShares held: Q3 2020 831.5k, Q4 2020 461.3k, Q1 2021 332.5k, Q2 2021 359.6k +27.1k +27,103 8.2%
73 IQVIA HLDGS INC COM IQV IQV 177,400 $43.0m0.42% 0.42% AddedShares held: Q3 2020 2.9k, Q4 2020 2.9k, Q1 2021 1.8k, Q2 2021 177.4k +175.6k +175,600 9755.6%
74 TELADOC HEALTH INC COM TDOC TDOC 257,948 $42.9m0.42% 0.42% AddedShares held: Q3 2020 121.4k, Q4 2020 210.4k, Q1 2021 254.6k, Q2 2021 257.9k +3.4k +3,371 1.3%
75 BLACK DIAMOND THERAPEUTICS I COM BDTX BDTX 3,463,000 $42.2m0.41% 0.41% AddedShares held: Q3 2020 1.4m, Q4 2020 1.4m, Q1 2021 2.2m, Q2 2021 3.5m +1.2m +1,220,000 54.4%
76 GLAUKOS CORP COM GKOS GKOS 495,432 $42.0m0.41% 0.41% AddedShares held: Q3 2020 515.8k, Q4 2020 449.3k, Q1 2021 489.3k, Q2 2021 495.4k +6.1k +6,090 1.2%
77 HEALTH CATALYST INC COM HCAT HCAT 753,621 $41.8m0.41% 0.41% AddedShares held: Q3 2020 521.9k, Q4 2020 620.2k, Q1 2021 741.9k, Q2 2021 753.6k +11.8k +11,766 1.6%
78 TELEFLEX INCORPORATED COM TFX TFX 100,161 $40.2m0.39% 0.39% ReducedShares held: Q3 2020 78.6k, Q4 2020 117.8k, Q1 2021 121.4k, Q2 2021 100.2k -21.2k -21,200 -17.5%
79 MERSANA THERAPEUTICS INC COM COM 2,941,000 $39.9m0.39% 0.39% AddedShares held: Q3 2020 0, Q4 2020 1.9m, Q1 2021 2.9m, Q2 2021 2.9m +91.0k +90,990 3.2%
80 ADAPTIVE BIOTECHNOLOGIES COR COM ADPT ADPT 962,352 $39.3m0.38% 0.38% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 962.4k
81 OPTION CARE HEALTH INC COM NEW OPCH OPCH 1,790,192 $39.2m0.38% 0.38% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 1.5m, Q2 2021 1.8m +281.9k +281,872 18.7%
82 HORIZON THERAPEUTICS PUB L SHS HZNP HZNP 417,700 $39.1m0.38% 0.38% AddedShares held: Q3 2020 77.4k, Q4 2020 380.2k, Q1 2021 408.5k, Q2 2021 417.7k +9.2k +9,200 2.2%
83 PHREESIA INC COM PHR PHR 622,542 $38.2m0.37% 0.37% AddedShares held: Q3 2020 427.0k, Q4 2020 472.7k, Q1 2021 613.0k, Q2 2021 622.5k +9.5k +9,529 1.6%
84 QUANTERIX CORP COM QTRX QTRX 637,815 $37.4m0.37% 0.37% ReducedShares held: Q3 2020 723.7k, Q4 2020 713.0k, Q1 2021 697.4k, Q2 2021 637.8k -59.6k -59,617 -8.6%
85 NEOGENOMICS INC COM NEW NEO NEO 818,313 $37.0m0.36% 0.36% AddedShares held: Q3 2020 426.9k, Q4 2020 548.4k, Q1 2021 788.0k, Q2 2021 818.3k +30.4k +30,360 3.9%
86 ABBVIE INC COM ABBV ABBV 324,200 $36.5m0.36% 0.36% ReducedShares held: Q3 2020 37.0k, Q4 2020 375.5k, Q1 2021 384.1k, Q2 2021 324.2k -59.9k -59,900 -15.6%
87 ILLUMINA INC COM ILMN ILMN 75,330 $35.6m0.35% 0.35% AddedShares held: Q3 2020 58.5k, Q4 2020 52.4k, Q1 2021 60.9k, Q2 2021 75.3k +14.4k +14,412 23.7%
88 EXACT SCIENCES CORP COM EXAS EXAS 275,673 $34.3m0.33% 0.33% AddedShares held: Q3 2020 304.5k, Q4 2020 195.0k, Q1 2021 218.1k, Q2 2021 275.7k +57.5k +57,533 26.4%
89 HUTCHMED CHINA LTD SPONSORED ADS HCM HCM 864,760 $34.0m0.33% 0.33% ReducedShares held: Q3 2020 947.7k, Q4 2020 947.7k, Q1 2021 975.5k, Q2 2021 864.8k -110.7k -110,728 -11.3%
90 AMGEN INC COM AMGN AMGN 129,580 $31.6m0.31% 0.31% ReducedShares held: Q3 2020 179.6k, Q4 2020 218.0k, Q1 2021 176.4k, Q2 2021 129.6k -46.9k -46,860 -26.6%
91 MASIMO CORP COM MASI MASI 127,713 $31.0m0.30% 0.30% AddedShares held: Q3 2020 102.2k, Q4 2020 107.8k, Q1 2021 126.2k, Q2 2021 127.7k +1.5k +1,517 1.2%
92 NEVRO CORP COM NVRO NVRO 183,201 $30.4m0.30% 0.30% AddedShares held: Q3 2020 120.6k, Q4 2020 130.4k, Q1 2021 181.0k, Q2 2021 183.2k +2.2k +2,188 1.2%
93 ATRICURE INC COM ATRC ATRC 374,418 $29.7m0.29% 0.29% ReducedShares held: Q3 2020 0, Q4 2020 556.4k, Q1 2021 497.7k, Q2 2021 374.4k -123.3k -123,294 -24.8%
94 COOPER COS INC COM NEW COM NEW 74,266 $29.4m0.29% 0.29% AddedShares held: Q3 2020 25.3k, Q4 2020 43.5k, Q1 2021 69.4k, Q2 2021 74.3k +4.9k +4,899 7.1%
95 BEIGENE LTD SPONSORED ADR ONC ONC 84,300 $28.9m0.28% 0.28% AddedShares held: Q3 2020 39.4k, Q4 2020 107.1k, Q1 2021 59.7k, Q2 2021 84.3k +24.6k +24,600 41.2%
96 1LIFE HEALTHCARE INC COM COM 836,190 $27.6m0.27% 0.27% AddedShares held: Q3 2020 468.6k, Q4 2020 637.6k, Q1 2021 823.1k, Q2 2021 836.2k +13.1k +13,055 1.6%
97 AMERICAN WELL CORP CL A CL A 2,141,758 $26.9m0.26% 0.26% AddedShares held: Q3 2020 379.9k, Q4 2020 942.2k, Q1 2021 1.9m, Q2 2021 2.1m +273.3k +273,325 14.6%
98 VOCERA COMMUNICATIONS INC COM VCRA VCRA 652,832 $26.0m0.25% 0.25% AddedShares held: Q3 2020 201.4k, Q4 2020 268.2k, Q1 2021 492.1k, Q2 2021 652.8k +160.7k +160,725 32.7%
99 BRIGHT HEALTH GROUP INC COM COM 1,500,000 $25.7m0.25% 0.25% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.5m
100 KEZAR LIFE SCIENCES INC COM COM 4,533,148 $24.6m0.24% 0.24% UnchangedShares held: Q3 2020 4.5m, Q4 2020 4.5m, Q1 2021 4.5m, Q2 2021 4.5m

Sold out since Q1 2021

SecurityTickerShares held beforeValue then
DAVITA INC DVA DVA 367,600 $39.6m367.6k shares
NUANCE COMMUNICATIONS INC NUAN NUAN 468,885 $20.5m468.9k shares
IRHYTHM TECHNOLOGIES INC IRTC IRTC 87,631 $12.2m87.6k shares
TABULA RASA HEALTHCARE INC TRHC TRHC 227,178 $10.5m227.2k shares
CUREVAC N V CVAC CVAC 28,900 $2.6m28.9k shares
GW PHARMACEUTICALS PLC GWPH GWPH 10,000 $2.2m10.0k shares
FIBROGEN INC 60,000 $2.1m60.0k shares
ASCENDIS PHARMA A/S 15,500 $2.0m15.5k shares
SAREPTA THERAPEUTICS INC SRPT SRPT 20,300 $1.5m20.3k shares
CARDINAL HEALTH INC CAH CAH 24,000 $1.5m24.0k shares
111 INC 85,000 $1.2m85.0k shares
UNIQURE NV QURE QURE 34,500 $1.2m34.5k shares
PAYCHEX INC PAYX PAYX 3,900 $382.0k3.9k shares
INTERCEPT PHARMACEUTICALS IN ICPT ICPT 8,000 $185.0k8.0k shares
VOYAGER THERAPEUTICS INC VYGR VYGR 31,800 $150.0k31.8k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
CUREVAC N V CVAC · Call CVACCall 70 $39.0k70 shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
VIRIDIAN THERAPEUTICS INC VRDN · 13G · filed 2026-05-15 VRDN 6.6%≈ $123.6m new 13G 2026-05-15
IMMUNOCORE HLDGS PLC IMCR · 13G · filed 2025-11-14 IMCR 5.6% new 13G 2025-11-14
JADE BIOSCIENCES INC JBIO · 13G · filed 2026-08-14 JBIO 5.0%≈ $67.9m -1.8 pts 13G 2026-08-14